Navigation Links
FDA Grants Market Clearance for the LipiScan(TM) Coronary Imaging System Developed by InfraReDx, Inc. - A Novel Spectroscopy System for the Identification of Lipid Core Containing Plaques of Interest in the Coronary Arteries
Date:4/29/2008

BURLINGTON, Mass., April 29 /PRNewswire/ -- InfraReDx, Inc. announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its catheter-based LipiScan(TM) Coronary Imaging System. The LipiScan device uses near-infrared spectroscopy to identify lipid core containing plaques of interest in the coronary arteries in patients already undergoing cardiac catheterization. Such plaques, which cannot be detected by commonly used tests such as a treadmill examination and even coronary angiography, are suspected to be the cause of most sudden cardiac deaths and non-fatal heart attacks.

The availability of this novel tool culminates a decade-long biomedical engineering effort to create an instrument that could perform spectroscopy in the arteries of patients with coronary artery disease. The identification of the chemical composition of coronary plaques is expected to be of value to cardiologists in the selection of medical, stenting or surgical therapy for coronary lesions. The device is also expected to be of value to the pharmaceutical industry as a means to assess the effect of novel anti-atherosclerotic agents on lipid core plaque burden.

"The InfraReDx team is pleased that the LipiScan System has been validated in tissue samples and a clinical study and has been cleared by the FDA for use in patients. We understand the great potential of interventional cardiology and anticipate that this novel tool will assist physicians with the complex decisions they face in the management of patients with coronary artery disease," says James E. Muller, M.D., cardiologist, co-founder, President and CEO of InfraReDx, Inc.

Dr. Muller noted that the creation of this novel device was greatly aided by the support and expertise of Sanderling Ventures of San Mateo, California. "Robert McNeil, Ph.D., Chairman of the Board of InfraReDx, and Timothy Mills, Ph.D., InfraReDx Board member are managing directors of Sanderlin
'/>"/>

SOURCE InfraReDx, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. US FDA Grants Orphan Drug Status to Immtechs Pafuramidine for Treatment of African Sleeping Sickness
2. Chinese SFDA Grants Immtech Fast Track Status
3. Ethics Group Asks USAID Inspector General to Investigate Legality of Grants to Soros Groups
4. NTMir Announces Research Grants for Epidemiology and Household Water as Source of Infection
5. FDA Grants Approval to Extend U.S. Enrollment and Clinical Trial
6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
7. FDA Grants Priority Review for ACIPHEX(R) (rabeprazole sodium) sNDA for Short-Term Treatment of GERD in Adolescents
8. FDA Grants Priority Review for PROMACTA(R) (eltrombopag)
9. FDA Grants NeoVistas Request to Expand CABERNET Trial to 30 Sites in the U.S.
10. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
11. FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...The Study Demonstrates microRNAs Extracted From a ...ffective Clinical Biomarkers for a Wide Range of ... Proprietary Technology, Rosetta Genomics is Curre...o Detect Colon Cancer, REHOVOT, Israel and JERSEY...ll/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG), a lea...
(Date:9/4/2008)...nother Roche first in TaqMan(R) real-time PCR test... lab, PLEASANTON, Calif., Sept. 4 /PRNewswir...s approved the Roche COBAS(R) TaqMan(R) HBV Test,... DNA approved in the U.S.,The test uses Roche,s re...epatitis B virus DNA in a patient,s blood. Doctors...
(Date:9/4/2008)...ivotal Study Seeks to Enroll 750 Women at More Tha...4 /- QuatRx Pharmaceuticals, a,privat...lopment and,commercialization of compounds to trea...s, today announced that it has initiated a second,...ablets), the company,s,estrogen-free oral therapy ...
(Date:9/4/2008)... Optimizing Patient Identification for Ta... of Personalized Treatment HUNTINGTON BEACH, Ca...ire/ -- Agendia, a world leader in molecular cance...tPrint(R), a new diagnostic test that,allows physi...ion levels of,the estrogen receptor (ER), progeste...
Breaking Medicine Technology:Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 2Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 3Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 4FDA Approves First Hepatitis B Viral Load Test 2FDA Approves First Hepatitis B Viral Load Test 3QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 2QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 3Agendia Launches TargetPrint(R) for Breast Cancer Patients 2DiObex and Camurus Sign License Agreement for the Development of DIO 901 in FluidCrystal 28R 29 Extended Release Technology 4031 1DiObex and Camurus Sign License Agreement for the Development of DIO 901 in FluidCrystal 28R 29 Extended Release Technology 4031 2Jazz Pharmaceuticals Inc Announces Expansion of Senior Debt 4030 1Jazz Pharmaceuticals Inc Announces Expansion of Senior Debt 4030 2Misys and Allscripts Create a Leader in Healthcare Software 4027 1Reducing HD risk naturally post menopause 14530 1Reducing HD risk naturally post menopause 14530 2
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
...epressants increase the risk of a gastrointestinal...reuptake inhibitors (SSRIs) are a group of antidep...e preferred over older drugs because they are rela...at Ottawa Hospital in Canada have just shown, they...
... that they "enjoy" their habit and don't fear the ...king involves powerful physiological and psycholog...ithout help only a minority succeed. Even smoking ...e helpful to many, have been unable to keep the ma...
...twice as likely to have a better quality of life a...uggests. Researchers in a Swiss study looked at pa... chronic angina. Doctors either gave them medicat...ty - a treatment where a fine tube with a small in...
...Centre and the Pentagon could affect the mental he... the dust settles over New York and Washington, ps...e full psychological impact of the disaster. Keepi...al keeps anxiety and grief at bay. And the sheer s...
Other Medicine News:
Features and Benefits: 1-12channel pipette This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-A
...ell plates in mind, Pipetman Ultra Multichannel is...tions: PCR* sequencing, immunology assays, series ...mond Tips from Gilson's patented Rocky Rack system...e productivity.,* PCR process is covered by US pat...
...ion, ergonomics, and value!, Comfortable feel and...andle , Finer control while pipetting with smooth,...ction with long, lever tip ejector , Completely au...ion without the need for recalibration , Easy-to-r...
Finnpipette Focus multichannel pipettes speed up repeat dispensing of reagents into microplates, with super blow-out for 0.1-10 l volumes. The improved ergonomic design of Finnpipette Focus multichan
Medicine Products: